206 related articles for article (PubMed ID: 22843889)
21. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.
Liu D; Sun L; Tong J; Chen X; Li H; Zhang Q
Tumour Biol; 2017 Jun; 39(6):1010428317701443. PubMed ID: 28631563
[TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation and suppression of glutathione peroxidase 3 are associated with inflammatory breast carcinogenesis.
Mohamed MM; Sabet S; Peng DF; Nouh MA; El-Shinawi M; El-Rifai W
Oxid Med Cell Longev; 2014; 2014():787195. PubMed ID: 24790704
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
Kang YH; Bae SI; Kim WH
J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells.
An BC; Jung NK; Park CY; Oh IJ; Choi YD; Park JI; Lee SW
Mol Cells; 2016 Aug; 39(8):631-8. PubMed ID: 27484907
[TBL] [Abstract][Full Text] [Related]
29. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.
Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y
Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma.
Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z
Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.
Hur K; Song SH; Lee HS; Ho Kim W; Bang YJ; Yang HK
Biochem Biophys Res Commun; 2003 Oct; 310(3):844-51. PubMed ID: 14550281
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation and expression of TIMP3 gene in gastric cancer.
Guan Z; Zhang J; Song S; Dai D
Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
[TBL] [Abstract][Full Text] [Related]
33. Cystatin M expression is reduced in gastric carcinoma and is associated with promoter hypermethylation.
Chen X; Cao X; Dong W; Xia M; Luo S; Fan Q; Xie J
Biochem Biophys Res Commun; 2010 Jan; 391(1):1070-4. PubMed ID: 20004178
[TBL] [Abstract][Full Text] [Related]
34. Promoter methylation and clinical significance of GPX3 in esophageal squamous cell carcinoma.
Lin Y; Zhang Y; Chen Y; Liu Z
Pathol Res Pract; 2019 Nov; 215(11):152676. PubMed ID: 31610903
[TBL] [Abstract][Full Text] [Related]
35. Association between GPX3 promoter methylation and malignant tumors: A meta-analysis.
Zhou C; Hu H; Zheng Z; Chen C; Li Y; Li B; Duan S
Pathol Res Pract; 2019 Jul; 215(7):152443. PubMed ID: 31085009
[TBL] [Abstract][Full Text] [Related]
36. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
37. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer.
Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X
Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764
[TBL] [Abstract][Full Text] [Related]
38. Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker.
Raja UM; Gopal G; Rajkumar T
Asian Pac J Cancer Prev; 2012; 13(11):5563-8. PubMed ID: 23317218
[TBL] [Abstract][Full Text] [Related]
39. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
40. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M
Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
